US2023098674A1PendingUtilityA1
Engineered tissue constructs
Est. expirySep 7, 2036(~10.2 yrs left)· nominal 20-yr term from priority
A61L 2430/02A61L 2300/414C12N 5/0655A61L 27/54A61K 35/32C12M 21/08A61L 2300/62A61L 27/3804C12M 25/14C12N 5/0697A61L 27/3839A61L 27/3886A61K 35/44A61L 2400/12A61L 27/58A61K 35/28C12N 2533/30A61K 35/42A61L 27/3817
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A modular engineered tissue construct includes a plurality of fused self-assembled, scaffold-free, high-density cell aggregates. At least one cell aggregate includes a plurality of cells and a plurality of biocompatible and biodegradable nanoparticles and/or microparticles that are incorporated within the cell aggregates. The nanoparticles and/or microparticles acting as a bulking agent within the cell aggregate to increase the cell aggregate size and/or thickness and improve the mechanical properties of the cell aggregate as well as to deliver bioactive agents.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A modular engineered tissue construct, comprising:
a plurality of fused self-assembled, scaffold-free, high-density cell aggregates, at least one cell aggregate including a plurality of cells and a plurality of biocompatible and biodegradable nanoparticles and/or microparticles that are incorporated within the cell aggregates, the nanoparticles and/or microparticles acting as a bulking agent within the cell aggregate to increase the cell aggregate size and/or thickness and improve the mechanical properties of the cell aggregate as well as to deliver bioactive agents.
12 . The modular engineered tissue construct of claim 11 , wherein the at least one of the fused ring-shaped self-assembled, scaffold-free, high-density cell aggregates comprises a plurality of chondrogenic cells that have been differentiated to form engineered cartilage.
13 . The modular engineered tissue construct of claim 11 , comprising alternating first engineered ring-shaped self-assembled, scaffold-free, high-density cell aggregates and second engineered ring-shaped self-assembled, scaffold-free, high-density cell aggregates fused to form a heterogenous modular tissue tube.
14 . The modular engineered tissue construct of claim 13 , wherein the first engineered ring-shaped self-assembled, scaffold-free, high-density cell aggregates define cartilaginous portions within the tube and the second engineered ring-shaped self-assembled, scaffold-free, high-density cell aggregates define noncartilaginous portions within the tube.
15 . The modular engineered tissue construct of claim 11 , the nanoparticles and/or microparticles comprising a biocompatible and biodegradable polymer.
16 - 25 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.